Products
Online Inquiry
3′,4′,7-Trihydroxyflavone
Cat. No.:
OB0225WX-2039
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
7,3',4'-Trihydroxyflavone is a flavonoid molecule that suppresses osteoclastogenesis by inhibiting the receptor activator of nuclear factor kappa B ligand (RANKL)-induced differentiation.
Synonym:
2150-11-0; 2-(3,4-dihydroxyphenyl)-7-hydroxy-4H-chromen-4-one; 3',4',7-Trihydroxyflavone; 2-(3,4-dihydroxyphenyl)-7-hydroxychromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-hydroxy-; 2-(3,4-Dihydroxyphenyl)-7-hydroxy-4H-1-benzopyran-4-one; Flavone, 7,3',4'-trihydroxy-; T 414; 104666-14-0; 3 inverted exclamation marka,4 inverted exclamation marka,7-Trihydroxyflavone; Flavone, 3',4',7-trihydroxy- (6CI,7CI,8CI); 2-(3,4-Dihydroxyphenyl)-7-hydroxy-4H-1-benzopyran-4-one; 3',4',7-Trihydroxyflavone; 3',4',7-Trihydroxylflavone; 5-Deoxyluteolin; 7,3',4'-Trihydroxyflavone; BRN 0253031; 4hlf; 2-(3,4-Dihydroxy-phenyl)-7-hydroxy-chromen-4-one; MFCD00017434
CAS No.:
2150-11-0
Compound CID:
5322065
Formula:
C15H10O5
Formula Weight:
270.24
Specification
Relative Density:
1.548 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
3',4',7-Trihydroxyflavone is employed in biochemical studies to investigate its radical scavenging capacity and its ability to inhibit the activation of specific pro-inflammatory transcription factors.
Library Information
Target:
p38 MAPK; NF-κB; ATPase
Receptor:
ATPase; NF-κB; Nuclear factor of activated Tcells (NFAT); p38 MAPK
Pathways:
NF-κB; MAPK; Membrane transporter/Ion channel
Plate Number:
AOCL-27
Plate Location:
b2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
55 mg/mL; 203.52 mM
